Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1

Reona Wada1, Shun Fujinuma1, Hirokazu Nakatsumi1

  • 1Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.

Journal of Biochemistry
|December 8, 2022
PubMed

Insights

Mechanistic target of rapamycin complex 1 (mTORC1) dephosphorylates pre-B cell leukemia transcription factor 2 (PBX2). This regulation involves glycogen synthase kinase 3 (GSK3) and protein phosphatase 1 (PP1), impacting PBX2 phosphorylation.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Biochemistry

Background:

  • Mechanistic target of rapamycin complex 1 (mTORC1) is a key kinase regulating cellular processes like protein synthesis and metabolism.
  • mTORC1 activity is influenced by extracellular signals, including nutrients and growth factors.
  • The precise phosphorylation targets of mTORC1 are not fully elucidated, necessitating further investigation.

Purpose of the Study:

  • To identify novel target molecules regulated by mTORC1.
  • To investigate the role of pre-B cell leukemia transcription factor 2 (PBX2) as a potential mTORC1 target.
  • To elucidate the mechanisms controlling PBX2 phosphorylation status.

Main Methods:

  • Reanalysis of large-scale phosphoproteomics data to identify mTORC1 targets.
  • Confirmation of PBX2 dephosphorylation downstream of mTORC1 using biochemical assays.
  • Pharmacological inhibition and gene knockdown experiments to identify kinases and phosphatases involved in PBX2 regulation.

Main Results:

  • Pre-B cell leukemia transcription factor 2 (PBX2) was identified as a novel direct target of mTORC1, undergoing dephosphorylation.
  • PBX2 dephosphorylation was confirmed to be dependent on mTORC1 activity.
  • Glycogen synthase kinase 3 (GSK3) was identified as the kinase responsible for PBX2 phosphorylation, while protein phosphatase 1 (PP1) mediates its dephosphorylation.

Conclusions:

  • The phosphorylation status of PBX2 is determined by the opposing activities of GSK3 and PP1.
  • mTORC1 signaling regulates PBX2 phosphorylation through the modulation of GSK3 and PP1.
  • These findings reveal a novel regulatory pathway for PBX2 within the mTORC1 signaling network.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K